Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9700186 | 0.95 | KCNH2 (0.45) | FFAR1MAPTMAPK1KCNH2ALDH1A1 | |
| SCHEMBL7680519 | 0.94 | KCNH2 (0.48) | FFAR1MAPTMAPK1KCNH2ALDH1A1 | |
| SCHEMBL8846088 | 0.94 | KCNH2 (0.48) | FFAR1MAPTMAPK1KCNH2ALDH1A1 | |
| SCHEMBL1852576 | 0.94 | KCNH2 (0.48) | FFAR1MAPTMAPK1KCNH2ALDH1A1 | |
| SCHEMBL10795164 | 0.94 | KCNH2 (0.48) | FFAR1MAPTMAPK1KCNH2ALDH1A1 | |
| SCHEMBL9559955 | 0.86 | FFAR1 (0.52) | FFAR1MAPTALDH1A1FFAR4HRH3 | |
| SCHEMBL30688451 | 0.81 | FFAR1 (0.50) | FFAR1ALDH1A1 | |
| SCHEMBL3899508 | 0.81 | FFAR1 (0.50) | FFAR1ALDH1A1 | |
| SCHEMBL6087379 | 0.80 | FFAR1 (0.47) | FFAR1MAPTKCNH2ALDH1A1FFAR4 | |
| SCHEMBL9442275 | 0.80 | MAOA (0.48) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2199290-B1 | Method of nucleating a polyolefin composition with acetal-based compounds | MILLIKEN & CO (US) | 2018-06-06 | — | — | EP | claimed |
| EP-2663542-B1 | PROCESS FOR THE PREPARATION OF ALDITOL ACETALS | RELIANCE IND LTD (IN) | 2016-07-06 | — | — | EP | claimed |
| US-9029575-B2 | Process for preparation of acetals | RELIANCE INDUSTRIES LIMITED (IN) | 2015-05-12 | — | — | US | claimed |
| US-8969595-B2 | Method of making diacetal compound in aqueous medium | RELIANCE INDUSTRIES LIMITED (IN) | 2015-03-03 | — | — | US | claimed |
| US-8871954-B2 | Process for the preparation of alditol acetals | RELIANCE INDUSTRIES LIMITED (IN) | 2014-10-28 | — | — | US | claimed |
| EP-2663541-A1 | METHOD OF MAKING DIACETAL COMPOUND IN AQUEOUS MEDIUM | Reliance Industries Limited (IN) | 2013-11-20 | — | — | EP | claimed |
| EP-2663542-A1 | PROCESS FOR THE PREPARATION OF ALDITOL ACETALS | Reliance Industries Limited (IN) | 2013-11-20 | — | — | EP | claimed |
| EP-2663569-A1 | PROCESS FOR PREPARING ALDITOL ACETALS | Reliance Industries Limited (IN) | 2013-11-20 | — | — | EP | claimed |
| US-20130303787-A1 | Process For Preparing Alditol Acetals | RELIANCE INDUSTRIES LIMITED (IN) | 2013-11-14 | — | — | US | claimed |
| US-20130296581-A1 | Process For The Preparation of Alditol Acetals | RELIANCE INDUSTRIES LIMITED (IN) | 2013-11-07 | — | — | US | claimed |
| EP-1740653-B1 | METHOD OF NUCLEATING A POLYOLEFIN COMPOSITION WITH ACETAL-BASED COMPOUNDS | MILLIKEN & CO (US) | 2010-08-18 | — | — | EP | claimed |
| EP-2199290-A2 | Method of nucleating a polyolefin composition with acetal-based compounds | Milliken & Company (US) | 2010-06-23 | — | — | EP | claimed |
| US-7262236-B2 | Acetal-based compositions | MILLIKEN & COMPANY (US) | 2007-08-28 | — | — | US | claimed |
| EP-1740653-A4 | METHOD OF NUCLEATING A POLYOLEFIN COMPOSITION WITH ACETAL-BASED COMPOUNDS | MILLIKEN & CO (US) | 2007-07-04 | — | — | EP | claimed |
| EP-1740653-A2 | METHOD OF NUCLEATING A POLYOLEFIN COMPOSITION WITH ACETAL-BASED COMPOUNDS | Milliken & Company (US) | 2007-01-10 | — | — | EP | claimed |
| US-7157510-B2 | Method of nucleating a polyolefin composition with acetal-based compounds | MILLIKEN & COMPANY (US) | 2007-01-02 | — | — | US | claimed |
| WO-2005111134-A2 | METHOD OF NUCLEATING A POLYOLEFIN COMPOSITION WITH ACETAL-BASED COMPOUNDS | MILLIKEN & COMPANY (US) | 2005-11-24 | — | — | WO | claimed |
| WO-2005108479-A2 | ACETAL-BASED COMPOSITIONS | MILLIKEN & COMPANY (US) | 2005-11-17 | — | — | WO | claimed |
| US-20050239928-A1 | Acetal-based compositions | MILLIKEN & COMPANY | 2005-10-27 | — | — | US | claimed |
| US-20050239926-A1 | Method of nucleating a polyolefin composition with acetal-based compounds | MILLIKEN & COMPANY | 2005-10-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239928-A1 | Acetal-based compositions | PCNA, RAD51, AR | FFAR1 1743/4885MAPT 2567/4885MAPK1 1865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.